BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35634239)

  • 1. HOXB9 mediates resistance to chemotherapy and patient outcomes through the TGFβ pathway in pancreatic cancer.
    Chiba N; Ochiai S; Gunji T; Kobayashi T; Sano T; Tomita K; Kawachi S
    Oncotarget; 2022; 13():747-754. PubMed ID: 35634239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic and functional analysis of ANGPTL4 overexpression in pancreatic cancer nominates targets that reverse chemoresistance.
    Gordon ER; Wright CA; James M; Cooper SJ
    BMC Cancer; 2023 Jun; 23(1):524. PubMed ID: 37291514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kindlin-2 induced by TGF-β signaling promotes pancreatic ductal adenocarcinoma progression through downregulation of transcriptional factor HOXB9.
    Zhan J; Song J; Wang P; Chi X; Wang Y; Guo Y; Fang W; Zhang H
    Cancer Lett; 2015 May; 361(1):75-85. PubMed ID: 25724625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Girdin interaction with vimentin induces EMT and promotes the growth and metastasis of pancreatic ductal adenocarcinoma.
    Wang W; Chen H; Gao W; Wang S; Wu K; Lu C; Luo X; Li L; Yu C
    Oncol Rep; 2020 Aug; 44(2):637-649. PubMed ID: 32467989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant NFATc1 signaling counteracts TGFβ-mediated growth arrest and apoptosis induction in pancreatic cancer progression.
    Hasselluhn MC; Schmidt GE; Ellenrieder V; Johnsen SA; Hessmann E
    Cell Death Dis; 2019 Jun; 10(6):446. PubMed ID: 31171768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylated HOXB9 at lysine 27 is of differential diagnostic value in patients with pancreatic ductal adenocarcinoma.
    Sun X; Song J; Zhang J; Zhan J; Fang W; Zhang H
    Front Med; 2020 Feb; 14(1):91-100. PubMed ID: 31372881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
    Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
    J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer.
    Weng CC; Hsieh MJ; Wu CC; Lin YC; Shan YS; Hung WC; Chen LT; Cheng KH
    Mol Cancer; 2019 May; 18(1):96. PubMed ID: 31109321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma.
    Dardare J; Witz A; Merlin JL; Gilson P; Harlé A
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the Hedgehog signaling pathway.
    Li H; Jiang W; Liu XN; Yuan LY; Li TJ; Li S; Xu SS; Zhang WH; Gao HL; Han X; Wang WQ; Wu CT; Yu XJ; Xu HX; Liu L
    Oncogene; 2020 Sep; 39(36):5825-5838. PubMed ID: 32753651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma.
    Matkar PN; Singh KK; Rudenko D; Kim YJ; Kuliszewski MA; Prud'homme GJ; Hedley DW; Leong-Poi H
    Oncotarget; 2016 Oct; 7(43):69489-69506. PubMed ID: 27542226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ID1 Mediates Escape from TGFβ Tumor Suppression in Pancreatic Cancer.
    Huang YH; Hu J; Chen F; Lecomte N; Basnet H; David CJ; Witkin MD; Allen PJ; Leach SD; Hollmann TJ; Iacobuzio-Donahue CA; Massagué J
    Cancer Discov; 2020 Jan; 10(1):142-157. PubMed ID: 31582374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition.
    Ramaker RC; Hardigan AA; Gordon ER; Wright CA; Myers RM; Cooper SJ
    BMC Cancer; 2021 May; 21(1):632. PubMed ID: 34049503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOXB9 promotes epithelial-to-mesenchymal transition via transforming growth factor-β1 pathway in hepatocellular carcinoma cells.
    Sha L; Dong L; Lv L; Bai L; Ji X
    Clin Exp Med; 2015 Feb; 15(1):55-64. PubMed ID: 25081022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
    Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A
    Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transition.
    Russell R; Perkhofer L; Liebau S; Lin Q; Lechel A; Feld FM; Hessmann E; Gaedcke J; Güthle M; Zenke M; Hartmann D; von Figura G; Weissinger SE; Rudolph KL; Möller P; Lennerz JK; Seufferlein T; Wagner M; Kleger A
    Nat Commun; 2015 Jul; 6():7677. PubMed ID: 26220524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Expression Comparison between Alcohol-Exposed versus Not Exposed Pancreatic Ductal Adenocarcinoma Patients Reveals a Peculiar TGFβ-Related Phenotype: An Exploratory Analysis.
    Doronzo A; Porcelli L; Marziliano D; Inglese G; Argentiero A; Azzariti A; Solimando AG
    Medicina (Kaunas); 2023 Apr; 59(5):. PubMed ID: 37241104
    [No Abstract]   [Full Text] [Related]  

  • 19. Long Non-Coding RNA
    Ko CC; Hsieh YY; Yang PM
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
    Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
    Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.